NCT02039349View on ClinicalTrials.gov

A Novel Compound for Alcoholism Treatment

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

January 3, 2014

Primary Completion Date

October 1, 2015

Study Completion Date

December 24, 2017

Conditions
AlcoholismAlcohol-Related DisordersAlcohol DependenceAlcohol Drinking Related ProblemsAlcohol Drinking
Interventions
DRUG

PF-05190457

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
collaborator

National Center for Advancing Translational Sciences (NCATS)

NIH

collaborator

University of Rhode Island

OTHER

lead

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

NCT02039349 - A Novel Compound for Alcoholism Treatment | Biotech Hunter | Biotech Hunter